Macrophage function in mice with a mutation at the microphthalmia (mi) locus

Proceedings of the Society for Experimental Biology and Medicine

Volumn 215, Issue 3, 1997, Pages 269-274

  Rohan, Patricia J ^a,b   Stechschulte, Daniel J ^a   Li, Yuai ^a   Dileepan, Kottarappat N ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; CYTOCHROME C; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE LOCUS; GENE MUTATION; MACROPHAGE FUNCTION; MALE; MICROPHTHALMIA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; TUMOR CELL;

ANIMALIA;

EID: 0030907006     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-215-44138     Document Type: Article

References (29)

1. Gruneberg H. The relations of microphthalmia and white in the mouse. J Genet 51:359-362, 1953.
2. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 190:784-785, 1975.
3. Stevens J, Loutit JF. Mast cells in spotted mutant mice (W Ph mi). Proc R Soc Lond 215:405-109, 1982.
4. Stechschulte DJ, Sharma R, Dileepan KN, Simpson KM, Aggarwal N, Clancy J Jr., Jilka RL. Effect of the mi allele on mast cells, basophils, natural killer cells and osteoclasts in C57BL/6J mice. J Cell Physiol 132:565-570, 1987.
5. Seaman WE, Gindhart TD, Greenspan JS, Blackman MA, Talal N. Natural killer cells, bone and the bone marrow: Studies in estrogen treated mice and in congenitally osteopetrotic (mi/mi) mice. J Immunol 122:2541-2547, 1979.
6. Chambers TJ, Loutit JF. A functional assessment of macrophages from osteopetrotic mice. J Pathol 129:57-63, 1979.
7. Stechschulte DJ Jr., Morris DC, Jilka RL, Stechschulte DJ, Dileepan KN. Impaired gastric acid secretion in mast cell-deficient mice. Am J Physiol 259:G41-G47, 1990.
8. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, Arnheiter H. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395-404, 1993.
9. Dileepan KN, Simpson KM, Stechschulte DJ. Modulation of macrophage superoxide-induced cytochrome c reduction by mast cells. J Lab Clin Med 113:577-585, 1989.
10. Shah BA, Li Y, Stechschulte DJ, Dileepan KN. Phagocytosis of mast cell granules results in decreased macrophage superoxide production. Mediators of Inflammation 4:406-412, 1995.
11. Dileepan KN, Lorsbach RB, Stechschulte DJ. Mast cell granules inhibit macrophage-mediated lysis of mastocytoma cells (P815) and nitric oxide production. J Leukoc Biol 53:446-453, 1993.
12. Yamada A, Dileepan KN, Stechschulte DJ, Suzuki T. Regulation of Fc δ 2a receptor-mediated phagocytosis by a murine macrophage-like cell line, P388D1: Involvement of casein kinase II activity associated with Fc δ 2a receptor. J Mol Cell Immunol 4:191-201, 1989.
13. Conrad RE. Induction and collection of peritoneal exudate macrophages. In: Herscowitz HB, Holden H, Bellanti J, Ghaffar A, Eds. Manual of Macrophage Methodology. New York: Marcell Dekker, Vol 13, Part 1, pp 5-11, 1981.
14. Stechschulte DJ, Austen KF. Phosphatidyl serine enhancement of antigen-induced mediation release from rat mast cells. J Immunol 112:970-978, 1974.
15. Babior BM, Kipnes RS, Curnette JP. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741-744, 1973.
16. Dileepan KN, Kennedy JA. Complete inhibition of dihydro-orotate oxidation and superoxide oxide production by 1,1;1-trifluoro-3-thenoylacetone. Biochem J 225:189-194, 1985.
17. Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142:290-296, 1984.
18. Stossel TP. Evaluation of opsonic and leukocyte function with a spectrophotometric test in patients with infection and with phagocytic disorders. Blood 42:121-130, 1973.
19. Burleson GR, Fuller LB, Menache MG, Graham JA. Poly (1):poly (C) enhanced alveolar and peritoneal macrophage phagocytosis: Quantitation by a new method utilizing fluorescent beads. Proc Soc Exp Biol Med 184:468-476, 1987.
20. McCord JM, Fridovich I. The utility of superoxide dismutase in studying free radical reaction. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide and oxygen. J Biol Chem 244:6049-6055, 1969.
21. Dileepan KN, Simpson KM, Lynch SR, Stechschulte DJ. Dismutation of eosinophil superoxide by mast cell granule superoxide dismutase. Biochem Arch 5:153-160, 1989.
22. Li Y, Ito N, Suzuki T, Stechschulte DJ, Dileepan KN. Dexamethasone inhibits nitric oxide-mediated cytotoxicity via effects on both macrophages and target cells. Immunopharmacol 30:177-186, 1995.
23. Stuehr DJ, Nathan CF. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543-1555, 1989.
24. Wershil BK, Murakami T, Galli SJ. Mast cell dependent amplification of an immunologically nonspecific inflammatory response. J Immunol 140:2356-2360, 1988.
25. Clark RA, Volpp BD, Leidal KG, Nauseef WM. Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 85:714-721, 1990.
26. Segal AW, Abo A. The biochemical basis of the NADPH oxidase of phagocytes. TIBS 18:43-47, 1993.
27. Chancock SJ, El-Benna J, Smith RM, Babior BM. The respiratory burst oxidase. J Biol Chem 269:24519-24522, 1994.
28. Henderson WR, Kaliner M. Immunologic and nonimmunologic generation of superoxide from mast cells and basophils. J Clin Invest 61:187-196, 1978.
29. Mirochnitchenko O, Inouye M. Effect of over expression of human Cu,Zn superoxide dismutase in transgenic mice on macrophage functions. J Immunol 156:1578-1586, 1996.